Objectives:
The aim of this study was to report the outcome of pregnancy in patients with chronic myeloid leukemia (CML) who were on imatinib for their treatment.
Methods:
We did retrospective analysis of data from January 1998 to December 2014; 104 patients met inclusion criteria for the study. We reported the result of 104 pregnancies in which the patient or her partner conceived while being on imatinib treatment for his or her CML. Results: There were 58 male and 46 female patients in total study population (n = 104). Patient distribution according to CML phase was as follows: 83 in the chronic phase (CML-CP), 20 in the accelerated phase, and one in the blast phase. Of the 46 female patients, 21 succumbed to abortion, and 25 had full-term pregnancy outcomes. The outcomes of all full-term pregnancy in the female partners of male CML patients were uneventful. During pre-imatinib era (total n = 6), patients were treated with hydroxy urea, interferon alpha, and/or therapeutic leukapheresis. A total of 10 of 19 pregnant patients (who were in complete cytogenic response [CCyR] and major molecular response [MMR] phase) continued imatinib until the time of delivery and had normal outcomes of full-term delivery (n = 7) and preterm delivery (n = 1), and two patients had congenital malformation (one omphalocele, one craniosynostosis). The remaining (9/19) patients (who were in CCyR and MMR before pregnancy) discontinued imatinib after counseling. Among these, eight patients had full-term normal delivery (two patients required leukapheresis), and one patient expired. But, two of nine patients did lose MMR during the third trimester. Conclusion: There is no standard of care regarding the best practice in the treatment of CML in case of pregnancy. Treatment options will include interferon and/or leukapheresis. Patients can have normal pregnancies with imatinib, but there might be risk of congenital anomalies as well.
Florid Cystic Endosalpingiosis of the Spleen
Aditya Talwar, MD, Alok Mohanty, MD, Suzanne Schiffman, MD, Jan Silverman, MD; Allegheny General Hospital, Pittsburgh, PA Endosalpingiosis is a condition in which fallopian tubelike epithelium is found outside the fallopian tubes. The etiology is unknown, although it is believed to arise from transformation of the coelomic epithelium and is usually an incidental finding. Endosalpingiosis can be encountered in any location and can sometimes clinically mimic other lesions. We describe a 47-year-old African-American woman who presented with a presumed history of a splenic cyst, which developed approximately two years ago. She underwent multiple drainages, with multiple recurrences. A CT scan in July 2016 revealed a cyst measuring 9.5 x 9 cm, with the radiologic impression of an abscess. A drain was placed; however, she was not treated with antibiotics. A follow-up CT scan showed a 6.5 x 6.3 cm cyst with air fluid level, and she underwent CT-guided drainage. The fluid culture grew alpha hemolytic step, and she was treated for an abscess. In November 2016, she underwent splenectomy, which showed a 7.4 x 4.9 x 4.0 cm multiloculated cyst. Histologically, the cyst demonstrated thick-walled septae and an epithelial lining that showed tubal-type glands with apical snouts. The cyst spaces also showed acidophilic fluid. The epithelium was positive for PAX-8, ER, CAM 5.2 and CK7, consistent with endosalpingiosis. In retrospect, splenic endosalpingiosis clinically mimicked a benign cyst or an abscess, and the positive culture most likely represents contamination in this case. Splenic endosalpingiosis needs to be considered in a cyst diagnosis when a clinically or radiologically suspected cyst or abscess is encountered in the spleen. A review of the literature only showed one other case report (APMIS, 2006 May; 114(5): 393-8) . This is the second case report of florid cystic endosalpingiosis of the spleen. Divya Sharma, MD, Steven Mann, MD, Jingmei Lin, MD, FASCP, Oscar Cummings, MD; Indiana University, Bloomington Objectives: IgG4-related disease is recognized as a fibro-inflammatory condition characterized by tendency to form tumefactive lesions, characteristic histopathologic appearance, and often but not always elevated serum IgG4 concentrations. IgG4-related disease involving the esophagus is extremely rare, with only four cases reported thus far. Methods: We describe IgG4-related disease of the esophagus in an 18-year-old man who presented with unexplained progressive dysphagia and weight loss of two-year duration. The barium fluoro esophagogram revealed prominent stricture involving distal 7-8 cm of the esophagus. Inability to dilate the stricture led to esophagectomy. Results: The esophageal resection specimen showed a dense transmural lymphoplasmacytic infiltrate with
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